N Biotechnol, 2013 · DOI: 10.1016/j.nbt.2013.04.007 · Published: June 25, 2013
Optogenetics allows remote manipulation of cellular functions in living organisms using light and genetic modification. Channelrhodopsins (ChR) are light-sensitive proteins that act as ion channels, opening upon exposure to light and causing cell activation. ChR2, a specific type, allows for very rapid cell depolarization. Introducing ChR2 into retinal ganglion cells can restore visual perception in mice suffering from retinal degeneration, demonstrating the potential of optogenetics in treating blindness.
Optogenetics offers a novel approach to treating retinal degenerative diseases by restoring light sensitivity to retinal cells.
Optogenetics provides a refined tool for investigating and manipulating neural circuits with high precision.
Optogenetics holds promise for broader applications in regenerative medicine by enabling light-controlled cellular functions and tissue regeneration.